Nektar Therapeutics market cap NKTR

Share price times shares outstanding: what the whole company sells for, since 2011.

Nektar Therapeutics is worth $1.3B at the close on Oct 23, 2026, at $37.22 a share.

That is up 11% over the last year and down 54% over five years.

Its highest close in our data was $17.4B in Mar 2018.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$1.3B	$748.8M	$2.8B	+40%
2025	$905M	$102.7M	$1.3B	+417%
2024	$175.1M	$97.2M	$323.2M	+62%
2023	$107.8M	$86.7M	$580.8M	−75%
2022	$424.8M	$404.1M	$2.3B	−83%
2021	$2.5B	$2B	$4.5B	−18%
2020	$3B	$2.8B	$4.7B	−20%
2019	$3.8B	$2.9B	$8B	−35%
2018	$5.8B	$5.3B	$17.4B	−38%
2017	$9.4B	$1.8B	$9.4B	+401%
2016	$1.9B	$1.5B	$2.6B	−17%
2015	$2.2B	$1.4B	$2.3B	+15%
2014	$2B	$1.3B	$2.1B	+48%
2013	$1.3B	$900.6M	$1.6B	+62%
2012	$815.4M	$655.7M	$1.2B	+27%
2011	$640.8M	$484M	$1.2B	n/a

Companies in Drug Manufacturers - General nearest Nektar Therapeutics' size, closest first, today.

Company	Market cap
NKTRNektar Therapeutics	$1.3B
OMEROmeros	$1.2B
PCRXPacira BioSciences	$1.5B
ANABAnaptysbio	$1.5B
AMPHAmphastar Pharmaceuticals	$1.1B
PAHCPhibro Animal Health	$1.6B
ANIPANI Pharmaceuticals	$1.7B
ABUSArbutus Biopharma	$831M
HRMYHarmony Biosciences	$2.1B
COLLCollegium Pharmaceutical	$747.5M
PBHPrestige Consumer Healthcare	$2.3B
Peer median	$1.5B